Inventor · Schlieren, CH

Leonardo Borras

28Patents
6h-index
9Co-inventors
58Inventor score

Filing activity: Mar 12, 2008 → Sep 13, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9090684B2 Stable and soluble antibodies inhibiting VEGF Chemistry; Metallurgy 28 Active
US8349322B2 Stable and soluble antibodies inhibiting VEGF Chemistry; Metallurgy 20 Active
US8293235B2 Humanization of rabbit antibodies using a universal antibody framework Chemistry; Metallurgy 15 Active
US8937162B2 Humanization of rabbit antibodies using a universal antibody framework Chemistry; Metallurgy 10 Active
US8673310B2 Stable and soluble antibodies inhibiting TNFα Chemistry; Metallurgy 9 Active
US9422366B2 Stable and soluble antibodies inhibiting TNF alpha Chemistry; Metallurgy 9 Active
US8545849B2 Stable and soluble antibodies Chemistry; Metallurgy 6 Active
US9873737B2 Stable and soluble antibodies inhibiting VEGF Chemistry; Metallurgy 6 Active
US10087244B2 Humanization of rabbit antibodies using a universal antibody framework Chemistry; Metallurgy 5 Active
US9593161B2 Humanization of rabbit antibodies using a universal antibody framework Chemistry; Metallurgy 5 Active
US10590193B2 Stable and soluble antibodies inhibiting VEGF Chemistry; Metallurgy 5 Active
US10100111B2 Stable and soluble antibodies inhibiting TNF alpha Chemistry; Metallurgy 5 Active
US8796425B2 Method for decreasing immunogenicity Chemistry; Metallurgy 2 Active
US10570198B2 Stable and soluble antibodies Chemistry; Metallurgy 2 Active
US8280711B2 Sequence based engineering and optimization of single chain antibodies Physics 2 Active
US9556265B2 Solubility optimization of immunobinders Chemistry; Metallurgy 2 Active
US9803027B2 Method for decreasing immunogenicity Chemistry; Metallurgy 1 Active
US11912771B2 MAGE-A4 peptide-MHC antigen binding proteins Chemistry; Metallurgy 1 Active
US9598487B2 Stable and soluble antibodies Chemistry; Metallurgy 1 Active
US12344663B2 Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases Physics 0 Active
US10221237B2 Solubility optimization of immunobinders Chemistry; Metallurgy 0 Active
US11046757B2 Solubility optimization of immunobinders Chemistry; Metallurgy 0 Active
US9938336B2 Sequence based engineering and optimization of single chain antibodies Physics 0 Active
US9908945B2 Sequence based engineering and optimization of single chain antibodies Physics 0 Active
US11578123B2 Stable and soluble antibodies inhibiting TNFα Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.